Management of bleeding in the terminally ill patient
- 1 June 2005
- journal article
- review article
- Published by Taylor & Francis in Hematology
- Vol. 10 (3) , 167-175
- https://doi.org/10.1080/10245330500093237
Abstract
Clinically significant bleeding occurs in approximately 6%-10% of patients in the palliative-care setting. Bleeding can range from persistent and small in quantity (but enough to interfere with a patient's quality of life), to catastrophic bleeding that ultimately leads to the rapid demise of the patient. Uncontrolled bleeding can be very distressing for staff, patients and families. Advanced planning is necessary in all bleeding circumstances. This session will review the types of cancer associated with bleeding, as well as management options for these situations. Emphasis will be placed on aspects of communication with families.Keywords
This publication has 42 references indexed in Scilit:
- Role of Coagulation and Fibrinolytic System in Prostate CancerSeminars in Thrombosis and Hemostasis, 2003
- Imatinib MesylateDrugs, 2003
- Oxidized cellulose dressings for persistent bleeding from a superficial malignant tumorAmerican Journal of Hospice and Palliative Medicine®, 2002
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Is there a role for melatonin in supportive care?Supportive Care in Cancer, 2002
- Treatment of intractable vaginal bleeding with formaldehyde soaked packsJournal of Obstetrics and Gynaecology, 2002
- Endoscopic Topical Placement of Formalin Soaked Pledgets to Control Localized Hemorrhage Due to Radiation CystitisJournal of Urology, 1997
- Fibrinolytic inhibitors for cancer-associated bleeding problemsJournal of Pain and Symptom Management, 1997
- Spontaneous rupture of hepatocellular carcinomaBritish Journal of Surgery, 1996
- Control of bleeding in advanced cancerThe Lancet, 1991